Skip to main content

Animations

MJFF Publications

4681 - 4690 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2025
  • 2025
  • 2025
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.75126
    Citation Count: 60
  • Summary Details
    OPEN
    Title: A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes13050727
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Hyposmia in Parkinson’s disease; exploring selective odour loss
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00922-3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Association between serum sodium and sporadic Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2025.1555831
    Citation Count: 1
  • Summary Details
    OPEN
    Title: An axonal brake on striatal dopamine output by cholinergic interneurons
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-025-01906-5
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2022.104476
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor function
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00607-8
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00371-7
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00375-3
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac177
    Citation Count: 65
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.